# Filing Detail

Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001493152-25-004528
Filing Date
2025-02-03
Accepted
2025-02-03 06:24:35
Documents
83

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | form424b4.htm iXBRL | 424B4 | 3002451
| Complete submission text file | 0001493152-25-004528.txt |  | 11897523

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL SCHEMA FILE | envb-20240930.xsd | EX-101.SCH | 81531
3 | XBRL CALCULATION FILE | envb-20240930_cal.xml | EX-101.CAL | 81921
4 | XBRL DEFINITION FILE | envb-20240930_def.xml | EX-101.DEF | 312377
5 | XBRL LABEL FILE | envb-20240930_lab.xml | EX-101.LAB | 629051
6 | XBRL PRESENTATION FILE | envb-20240930_pre.xml | EX-101.PRE | 485110
85 | EXTRACTED XBRL INSTANCE DOCUMENT | form424b4_htm.xml | XML | 2064773

Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-284277 | Film No.: 25580500
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)